GLP-1 news

Houston Pharmacy Behind Recalled Compounded Tirzepatide Vials Drew 14 FDA Inspection Observations, Including Exposed Skin and Research-Grade Ingredients

Illegal weight-loss drug retatrutide on the rise in the Netherlands

Black mold, bugs found at Chinese plants making GLP-1 compounding agents

Self-Reported Adverse Effects Among Social Media Users Taking Retatrutide

£2m fake weight-loss pens found in 'filthy' Birmingham hub

A trusted seal made these websites look legit. The weight-loss drug they sold wasn't.

Two deaths were reported to the FDA. Is the bootleg weight-loss drug "Reta" to blame?

Eli Lilly Sues More Vendors Selling ‘Illicit’ Weight Loss Drugs

Woman issues urgent warning after reta ‘nearly killed and 'paralyzed' her

The Pitfalls of Buying Unapproved GLP-1 Drugs

The Black Market for Investigational GLP-1 Drugs

Fake Obesity Shots and Unapproved Drugs Mar India’s Weight-Loss Boom

Iowa nurses face sanctions for alleged drug-related violations • Iowa Capital Dispatch

Two Indian Nationals Charged in Connection with Transnational

New warning over fake weight loss jabs and pills as 'health at risk'

Trafficking of Contraband Weight Loss Drugs From Paraguay to Brazil Spikes

FDA Warns Pharmacy About Illegal GLP-1 Compounding

AG Fitch Urges Administration to Protect GLP-1 Drugs from Chinese Exploitation | DeSoto County News

RX Border Defense

Over 250 searches carried out in the case involving counterfeit Biopatid

Novo Nordisk secures injunction over Ozempic, Wegovy claims

Patients duped as fake pharmacies sell counterfeit weight-loss drugs

Australia: Man takes counterfeit weight-loss drug, hospitalized with torn esophagus

Bank accounts frozen in MHRA weight-loss jab investigation

Retatutride: How the hunger for a new weight loss drug is feeding an industry of fakes

Peptide Partners LLC MARCS-CMS 735063

NuScience Peptides LLC - 733652 - 08/24/2026

Royal Peptides LLC - 734884 - 08/24/2026

Surge in unapproved, compounded GLP-1 drugs. Are they safe?

‘Who knows what they’re taking?’: people risk the gray market for the newest weight-loss drug